Regorafenib is a synthetic compound studied as an active pharmaceutical ingredient, characterized by an aromatic, halogen-containing structure. Its crystalline forms and monohydrate have been investigated for structural properties relevant to pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Regorafenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Regorafenib monohydrate
pharmaceutical raw material
Sorafenib
Multikinase inhibitor for cancer research
Sorafenib tosylate
pharmaceutical raw material
Flupirtine maleate
pharmaceutical raw material
(R)-colchicine
pharmaceutical raw material
Ingenol mebutate
pharmaceutical raw material
Fludarabine phosphate
pharmaceutical raw material
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
pharmaceutical intermediate
The international HS code for Regorafenib (CAS 755037-03-7) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
FNHKPVJBJVTLMP-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F
Sourcing Regorafenib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.